
Andy Hahn
@onchahn
Genitourinary Medical Oncologist @MDAndersonNews. Opinions are my own.
ID: 807059132033314816
09-12-2016 03:07:46
1,1K Tweet
1,1K Takipçi
465 Takip Edilen

Interesting results from KEYMAKER-U03 by Katy Beckermann Lenvatinib + belzutifan produced ORR of 47% whereas pembro + lenvatinib had ORR of 40%. Modest improvement of PFS. Lenvatinib seems to carry a lot of the benefit and toxicity of combos in this setting #ascoGU25
